Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront surgery.
Study Type
OBSERVATIONAL
Enrollment
22,500
Uhmontpellier
Montpellier, France
To study the prognostic effect of the volume of activity
To study the prognostic effect of the volume of activity per center on the risk of recurrence
Time frame: at 5 years
Verify that the therapeutic sequence
Verify that the therapeutic sequence of primary surgery and secondary chemotherapy is a good prognostic factor for overall and specific survival at 5 years
Time frame: at 5 years
Verify that delay in initiation of chemotherapy beyond 4 weeks
Verify that delay in initiation of chemotherapy beyond 4 weeks after surgery is a poor prognostic element on overall and specific survival at 5 years
Time frame: at 5 years
Verify that age is a poor prognostic element
Verify that age is a poor prognostic element for overall and specific survival at 5 years
Time frame: at 5 years
Verify that geographic distance
Verify that geographic distance from a clinical center is a poor prognostic element for overall and specific survival at 5 years
Time frame: at 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.